| A new quinoline BRD4 inhibitor targets a distinct latent HIV-1 reservoir for reactivation from other “shock” drugs E Abner, M Stoszko, L Zeng, HC Chen, A Izquierdo-Bouldstridge, ... Journal of Virology 92 (10), 10.1128/jvi. 02056-17, 2018 | 52 | 2018 |
| Quercetin blocks Ebola virus infection by counteracting the VP24 interferon-inhibitory function E Fanunza, M Iampietro, S Distinto, A Corona, M Quartu, E Maccioni, ... Antimicrobial agents and chemotherapy 64 (7), 10.1128/aac. 00530-20, 2020 | 47 | 2020 |
| APOBECs and herpesviruses AZ Cheng, SN Moraes, NM Shaban, E Fanunza, CJ Bierle, PJ Southern, ... Viruses 13 (3), 390, 2021 | 42 | 2021 |
| Identification of myricetin as an ebola virus VP35–double-stranded RNA interaction inhibitor through a novel fluorescence-based assay GL Daino, A Frau, C Sanna, D Rigano, S Distinto, V Madau, F Esposito, ... Biochemistry 57 (44), 6367-6378, 2018 | 38 | 2018 |
| Insights into Ebola virus VP35 and VP24 interferon inhibitory functions and their initial exploitation as drug targets E Fanunza, A Frau, A Corona, E Tramontano Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious …, 2019 | 26 | 2019 |
| Zika virus NS2A inhibits interferon signaling by degradation of STAT1 and STAT2 E Fanunza, F Carletti, M Quartu, N Grandi, L Ermellino, J Milia, A Corona, ... Virulence 12 (1), 1580-1596, 2021 | 23 | 2021 |
| INMI1 zika virus NS4B antagonizes the interferon signaling by suppressing STAT1 phosphorylation E Fanunza, N Grandi, M Quartu, F Carletti, L Ermellino, J Milia, A Corona, ... Viruses 13 (12), 2448, 2021 | 21 | 2021 |
| Intracellular human antibody fragments recognizing the VP35 protein of Zaire Ebola filovirus inhibit the protein activity M Flego, A Frau, L Accardi, A Mallano, A Ascione, M Gellini, E Fanunza, ... BMC biotechnology 19, 1-12, 2019 | 21 | 2019 |
| Development and validation of a novel dual luciferase reporter gene assay to quantify ebola virus VP24 inhibition of IFN signaling E Fanunza, A Frau, M Sgarbanti, R Orsatti, A Corona, E Tramontano Viruses 10 (2), 98, 2018 | 21 | 2018 |
| Antiviral agents against Ebola virus infection: repositioning old drugs and finding novel small molecules E Fanunza, A Frau, A Corona, E Tramontano Annual reports in medicinal chemistry 51, 135-173, 2018 | 19 | 2018 |
| Relevance of Ebola virus VP35 homo-dimerization on the type I interferon cascade inhibition F Di Palma, GL Daino, VK Ramaswamy, A Corona, A Frau, E Fanunza, ... Antiviral Chemistry and Chemotherapy 27, 2040206619889220, 2019 | 17 | 2019 |
| Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production A Corona, E Fanunza, C Salata, MJ Morwitzer, S Distinto, L Zinzula, ... Antiviral research 198, 105251, 2022 | 10 | 2022 |
| The Methanolic Extract of Perilla frutescens Robustly Restricts Ebola Virus Glycoprotein-Mediated Entry YT Kuo, CH Liu, A Corona, E Fanunza, E Tramontano, LT Lin Viruses 13 (9), 1793, 2021 | 5 | 2021 |
| Mitochondrial double-stranded RNA triggers induction of the antiviral DNA deaminase APOBEC3A and nuclear DNA damage C Wick, SA Moghadasi, JT Becker, E Fanunza, S Oh, E Bournique, ... Journal of Biological Chemistry 299 (9), 2023 | 2 | 2023 |
| Human cytomegalovirus mediates APOBEC3B relocalization early during infection through a ribonucleotide reductase-independent mechanism E Fanunza, AZ Cheng, AA Auerbach, B Stefanovska, SN Moraes, ... Journal of virology 97 (8), e00781-23, 2023 | 1 | 2023 |
| Mutation of Ebola virus VP35 Ser129 uncouples interferon antagonist and replication functions MJ Morwitzer, A Corona, L Zinzula, E Fanunza, C Nigri, S Distinto, ... bioRxiv, 726935, 2019 | 1 | 2019 |
| Viruses, innate immunity, and antiviral strategies: from basic research to clinical applications E Fanunza, A Corona Frontiers in Cellular and Infection Microbiology 13, 2023 | | 2023 |
| The Methanolic Extract of Perilla frutescens Robustly Restricts Ebola Virus Glycoprotein-Mediated Entry. Viruses 2021, 13, 1793 YT Kuo, CH Liu, A Corona, E Fanunza, E Tramontano, LT Lin s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | | 2021 |
| Evasion of IFN Signaling by Ebola Virus and Zika Virus: Characterization and Exploitation of Viral Proteins as Drug Targets E Fanunza Università degli Studi di Cagliari, 2019 | | 2019 |
| 1, 5-Dicaffeoylquinic Acid Blocks EBOV Replication Counteracting the IFN-beta Production Inhibition by the VP35 Ebola Virus Protein A Corona, E Fanunza, C Salata, P St Reid, S Distinto, C Sanna, ... PROGRAM and ABSTRACTS, 80-80, 2019 | | 2019 |
